Daniel Hart - Avid Bioservices Chief Officer
| CDMO Stock | USD 6.83 0.15 2.25% |
Executive
Mr. Daniel R. Hart is Chief Financial Officer of the Company, effective August 1, 2018. He has served as Chief Financial Officer since August 1, 2018 and has over 20 years of finance and accounting experience. Mr. Hart is responsible for overseeing and managing all of our accounting and finance functions. Prior to joining us, Mr. Hart served as Chief Financial Officer of ENO Holdings, Inc., a family of companies focused on the residential real estate market with offerings spanning brokerage, franchisor, property management, title and escrow services. While with ENO Holdings, he helped optimize the groups accounting and finance department with a focus on establishing repeatable processes in the areas of financial statements, operating plans, cash forecasts and organization budgets. Prior to that position, Mr. Hart served as Senior Vice President, Chief Financial Officer and Assistant Secretary at SMA, a 100 million private equity owned management consulting firm that was previously a Nasdaqlisted company. During his time at SMA, which included several financial leadership positions of increasing responsibility, he was responsible for overseeing financial stewardship and played a central role in various financial transactions and corporate acquisitions since 2018.
| Age | 51 |
| Tenure | 6 years |
| Address | 14191 Myford Road, Tustin, CA, United States, 92780 |
| Phone | 714-508-6100 |
| Web | https://www.avidbio.com |
Avid Bioservices Management Efficiency
The company has return on total asset (ROA) of (0.0136) % which means that it has lost $0.0136 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0628) %, meaning that it created substantial loss on money invested by shareholders. Avid Bioservices' management efficiency ratios could be used to measure how well Avid Bioservices manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Avid Bioservices' Return On Tangible Assets are very stable compared to the past year. As of the 24th of April 2024, Return On Assets is likely to grow to 0, while Return On Capital Employed is likely to drop (0.01). At this time, Avid Bioservices' Net Tangible Assets are very stable compared to the past year. As of the 24th of April 2024, Return On Tangible Assets is likely to grow to 0, while Other Current Assets are likely to drop about 1.2 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Gopi MBA | Larimar Therapeutics | 53 | |
| Zhiyong Hou | Dyne TherapeuticsInc | 55 | |
| Matthew Moyle | AnaptysBio | 54 | |
| Andrew Callos | Cytokinetics | 55 | |
| Marco Londei | AnaptysBio | 62 | |
| Lily Hepworth | Immunocore Holdings | N/A | |
| YulyMae DiNapoli | Cytokinetics | N/A | |
| JeanLuc Girardet | Mirum Pharmaceuticals | N/A | |
| Martin Dahl | AnaptysBio | N/A | |
| Danielle Bradbury | Mineralys Therapeutics Common | N/A | |
| Marc Wilson | Crinetics Pharmaceuticals | 45 | |
| Priya Raina | AnaptysBio | N/A | |
| Jeff Lotz | Cytokinetics | N/A | |
| Corinne Noyes | Lyra TherapeuticsInc | 56 | |
| Monique Silva | AnaptysBio | N/A | |
| Tim Randall | MeiraGTx Holdings PLC | N/A | |
| Bruce Gottlieb | MeiraGTx Holdings PLC | 42 | |
| Elizabeth Broder | MeiraGTx Holdings PLC | N/A | |
| Yan Cheng | Dyne TherapeuticsInc | 54 | |
| MaryAlice JD | Acrivon Therapeutics Common | 50 | |
| Vinita Kumar | Mirum Pharmaceuticals | N/A | |
Management Performance
| Return On Equity | -0.0628 | ||||
| Return On Asset | -0.0136 |
Avid Bioservices Leadership Team
Elected by the shareholders, the Avid Bioservices' board of directors comprises two types of representatives: Avid Bioservices inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avid. The board's role is to monitor Avid Bioservices' management team and ensure that shareholders' interests are well served. Avid Bioservices' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avid Bioservices' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shelley Fussey, Vice President - Intellectual Property | ||
| Daniel Hart, Chief Officer | ||
| Stephen Hedberg, Principal Financial Officer, Principal Accounting Officer | ||
| Mark Ziebell, Vice President General Counsel, Corporate Secretary | ||
| Oksana Lukash, Vice People | ||
| Paul Lytle, CFO | ||
| Catherine Mackey, Independent Director | ||
| Roger Lias, President CEO | ||
| Gregory Sargen, Director | ||
| Harold MD, Medical Advisor | ||
| Mark Bamforth, Independent Director | ||
| Mark JD, General VP | ||
| Patrick Walsh, Independent Director | ||
| Prof Brekken, Medical Advisor | ||
| Richard Hancock, Director | ||
| Prof Schroit, Medical Advisor | ||
| Joel McComb, Director | ||
| Joseph Carleone, Director | ||
| Matthew Kwietniak, Chief Officer | ||
| Magnus Schroeder, Vice President - Process Sciences | ||
| Richard Richieri, Chief Officer | ||
| Tracy Kinjerski, VP Operations |
Avid Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avid Bioservices a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0628 | ||||
| Return On Asset | -0.0136 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | (0.44) % | ||||
| Current Valuation | 570.64 M | ||||
| Shares Outstanding | 63.24 M | ||||
| Shares Owned By Insiders | 1.10 % | ||||
| Shares Owned By Institutions | 92.60 % | ||||
| Number Of Shares Shorted | 10.11 M | ||||
| Price To Earning | 10.76 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Avid Bioservices in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Avid Bioservices' short interest history, or implied volatility extrapolated from Avid Bioservices options trading.
Pair Trading with Avid Bioservices
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avid Bioservices position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avid Bioservices will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Avid Bioservices could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avid Bioservices when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avid Bioservices - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avid Bioservices to buy it.
The correlation of Avid Bioservices is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avid Bioservices moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avid Bioservices moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avid Bioservices can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avid Bioservices. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Avid Stock analysis
When running Avid Bioservices' price analysis, check to measure Avid Bioservices' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avid Bioservices is operating at the current time. Most of Avid Bioservices' value examination focuses on studying past and present price action to predict the probability of Avid Bioservices' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avid Bioservices' price. Additionally, you may evaluate how the addition of Avid Bioservices to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is Avid Bioservices' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avid Bioservices. If investors know Avid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avid Bioservices listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.80) | Earnings Share (0.18) | Revenue Per Share 2.246 | Quarterly Revenue Growth (0.27) | Return On Assets (0.01) |
The market value of Avid Bioservices is measured differently than its book value, which is the value of Avid that is recorded on the company's balance sheet. Investors also form their own opinion of Avid Bioservices' value that differs from its market value or its book value, called intrinsic value, which is Avid Bioservices' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avid Bioservices' market value can be influenced by many factors that don't directly affect Avid Bioservices' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avid Bioservices' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avid Bioservices is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avid Bioservices' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.